CN Stock MarketDetailed Quotes

Shenzhen Kangtai Biological Products (300601)

Watchlist
  • 12.99
  • 0.000.00%
15min DelayPre-Opening Auction Sep 22 09:30 CST
14.51BMarket Cap175.54P/E (TTM)

Shenzhen Kangtai Biological Products (300601) Income Statement

Quarterly·All
YOY yoy
Hide blank lines yoy
Currency: CNY
2026/H1
2026/Q1
2025/FY
2025/Q9
2025/H1
2025/Q1
2024/FY
2024/Q9
2024/H1
2024/Q1
2023/FY
2023/Q9
2023/H1
2023/Q1
2022/FY
2022/Q9
2022/H1
2022/Q1
2021/FY
2021/Q9
Total Operating Revenue
-8.55%1.27B
-2.18%631.11M
+0.81%2.67B
+2.24%2.06B
+15.81%1.39B
+42.85%645.20M
-23.75%2.65B
-18.11%2.02B
-30.54%1.20B
-39.65%451.66M
+10.14%3.48B
-3.92%2.46B
-5.32%1.73B
-14.12%748.38M
-13.55%3.16B
+7.90%2.57B
+73.72%1.83B
+214.60%871.43M
+61.51%3.65B
+67.37%2.38B
Operating Revenue
-8.55%1.27B
-2.18%631.11M
+0.81%2.67B
+2.24%2.06B
+15.81%1.39B
+42.85%645.20M
-23.75%2.65B
-18.11%2.02B
-30.54%1.20B
-39.65%451.66M
+10.14%3.48B
-3.92%2.46B
-5.32%1.73B
-14.12%748.38M
-13.55%3.16B
+7.90%2.57B
+73.72%1.83B
+214.60%871.43M
+61.51%3.65B
+67.37%2.38B
Other Operating Revenues
+43.55%5.69M
----
+36.94%12.17M
----
+34.45%3.96M
----
-18.49%8.88M
----
+161.65%2.95M
----
-61.23%10.90M
----
-82.59%1.13M
----
+1107.84%28.11M
----
+1520.31%6.47M
----
+0.38%2.33M
----
Total Operating Cost
-7.64%1.19B
+0.83%599.37M
+8.84%2.50B
+20.52%1.93B
+27.76%1.29B
+41.46%594.45M
-10.43%2.30B
-7.79%1.60B
-14.28%1.01B
-16.40%420.22M
-1.84%2.57B
-12.56%1.73B
-10.00%1.18B
-10.46%502.64M
+22.72%2.62B
+63.33%1.98B
+83.61%1.31B
+111.45%561.39M
+39.12%2.13B
+30.07%1.21B
Cost of Sales
+9.03%365.02M
+6.50%182.40M
+41.72%676.61M
+61.74%540.26M
+71.67%334.79M
+137.99%171.26M
-11.21%477.42M
-2.85%334.02M
-14.98%195.01M
-31.75%71.96M
+7.55%537.67M
+3.29%343.81M
-5.75%229.38M
-13.83%105.44M
-49.32%499.95M
-8.83%332.86M
+48.65%243.38M
+207.28%122.35M
+335.88%986.43M
+262.50%365.10M
Operating Tax Surcharges
+5.17%19.10M
+70.86%6.96M
+18.15%36.10M
+26.26%22.05M
+32.98%18.16M
+47.35%4.07M
+19.27%30.55M
+14.97%17.46M
+17.85%13.66M
-33.70%2.76M
+25.02%25.62M
-2.38%15.19M
+2.67%11.59M
-5.43%4.17M
+1.66%20.49M
+0.94%15.56M
+27.31%11.29M
+66.50%4.41M
+39.43%20.16M
+91.57%15.41M
Operating Expense
-7.85%433.32M
+11.10%231.13M
+0.80%894.39M
+3.00%691.52M
+18.48%470.24M
+30.22%208.03M
-27.95%887.25M
-20.59%671.40M
-33.46%396.90M
-38.37%159.76M
+13.36%1.23B
-4.64%845.52M
-1.75%596.44M
-10.23%259.20M
+87.87%1.09B
+81.70%886.66M
+75.70%607.04M
+138.14%288.73M
-34.17%578.24M
-15.12%487.97M
Administrative Expenses
-1.83%155.61M
-14.10%71.66M
-16.32%311.42M
-7.15%227.14M
-9.38%158.52M
+13.48%83.42M
+35.06%372.14M
+42.76%244.62M
+74.85%174.93M
+42.33%73.52M
+19.70%275.53M
-8.33%171.35M
-22.19%100.05M
-10.37%51.65M
-9.08%230.18M
+15.56%186.91M
+25.78%128.57M
+14.63%57.63M
+50.33%253.17M
+33.48%161.75M
Research and Development
-41.01%175.16M
-30.13%84.28M
+6.95%543.42M
+34.74%420.07M
+34.85%296.92M
+12.10%120.63M
+1.47%508.12M
-13.03%311.77M
-10.06%220.19M
+27.40%107.61M
-37.55%500.75M
-38.28%358.50M
-28.01%244.81M
-11.65%84.47M
+126.34%801.86M
+161.34%580.88M
+171.59%340.07M
+44.24%95.60M
+32.65%354.26M
+56.27%222.27M
Financial Expense
+216.45%46.22M
+226.05%22.93M
+65.48%42.95M
+32.70%24.28M
+26.44%14.61M
+52.54%7.03M
+1764.22%25.95M
+1067.12%18.29M
+945.74%11.55M
+301.86%4.61M
+92.63%-1.56M
+91.24%-1.89M
+92.53%-1.37M
+68.88%-2.28M
+64.24%-21.15M
+45.28%-21.60M
+40.88%-18.29M
+50.29%-7.34M
-176.44%-59.17M
-172.72%-39.47M
-Interest Financial Expense
+0.86%59.25M
+0.02%29.50M
-4.10%119.03M
-4.52%88.87M
-7.52%58.74M
-10.03%29.49M
+9.15%124.12M
+10.96%93.08M
+14.43%63.52M
+19.27%32.78M
+4.35%113.71M
+3.65%83.88M
+3.27%55.51M
+4.74%27.48M
+99.90%108.97M
+231.74%80.93M
+2632.07%53.76M
+8394.19%26.24M
+2231.92%54.51M
+960.91%24.40M
-Interest Financial Income
+62.83%-16.63M
+62.32%-8.60M
+20.75%-77.97M
+12.74%-65.60M
+13.90%-44.75M
+19.25%-22.82M
+14.91%-98.39M
+12.63%-75.17M
+8.71%-51.97M
+5.19%-28.26M
+12.82%-115.62M
+18.29%-86.04M
+23.19%-56.93M
+15.78%-29.81M
-15.41%-132.62M
-63.50%-105.30M
-122.65%-74.12M
-130.63%-35.40M
-377.57%-114.91M
-280.22%-64.40M
Credit Impairment Loss
+2.40%-27.14M
-53.04%-12.21M
-43.78%-42.38M
+8.71%-34.27M
+22.91%-27.80M
+36.86%-7.98M
-130.45%-29.48M
+3.32%-37.53M
+3.88%-36.07M
+7.93%-12.64M
+67.61%-12.79M
-52.85%-38.83M
-72.69%-37.52M
-82.63%-13.73M
-278.02%-39.48M
-258.79%-25.40M
-535.76%-21.73M
-995.81%-7.52M
+49.01%-10.45M
+63.35%-7.08M
Asset Impairment Loss
+60.95%-36.57M
+126.91%6.00M
+42.19%-133.83M
-23.08%-128.80M
-37.15%-93.67M
-6352.47%-22.31M
-94.91%-231.52M
-137.65%-104.64M
-58.19%-68.29M
+96.02%-345.73K
+86.75%-118.79M
+90.91%-44.03M
+90.38%-43.17M
+14.76%-8.70M
-478.53%-896.49M
-1680.90%-484.29M
-9032.34%-448.71M
-421.33%-10.20M
-3614.66%-154.96M
-1218.47%-27.19M
Fair Value Change Income
+25321.82%14.82M
--7.60M
+282.99%5.29M
-52.73%441.90K
-93.18%58.30K
-100.00%0.00
+618.46%1.38M
+672.60%934.77K
+3401.25%854.67K
--782.67K
-93.95%192.20K
-66.33%120.99K
-92.76%24.41K
-100.00%0.00
--3.18M
+101.27%359.36K
+101.16%337.06K
-99.15%93.63K
-100.00%0.00
---28.32M
Investment income
+1412.87%1.50M
--124.34K
+224.50%1.51M
-72.08%134.48K
-79.40%99.25K
--0.00
-72.62%465.02K
-71.63%481.74K
-71.63%481.74K
----
+79.88%1.70M
+1699.78%1.70M
--1.70M
--1.47M
-96.82%944.05K
-99.83%94.35K
-100.00%0.00
----
+117.21%29.71M
+116.67%56.57M
Asset Deal Income
+101.56%5.69K
+100.00%0.00
+88.90%-934.47K
-2713.80%-365.80K
-483.69%-365.90K
-360.84%-185.22K
-525.24%-8.42M
+97.40%-13.00K
-89.10%95.36K
--71.01K
-1156.20%-1.35M
-426.13%-499.78K
+464.11%874.78K
--0.00
+370.38%127.43K
+592.16%153.25K
+280.19%155.07K
----
+109.28%27.09K
+106.84%22.14K
Other Revenues
-37.37%15.40M
-6.18%7.38M
-59.18%40.21M
-50.04%30.62M
-55.94%24.59M
-84.47%7.86M
-42.72%98.51M
-48.20%61.28M
-41.13%55.80M
+158.80%50.63M
+131.05%171.99M
+51.87%118.30M
+123.53%94.79M
-43.76%19.56M
+8.03%74.44M
+103.83%77.89M
+24.76%42.40M
+812.73%34.79M
+141.30%68.91M
+119.20%38.21M
Operating Profit
+2599.59%46.58M
+44.42%40.64M
-78.99%38.07M
-98.27%5.89M
-98.79%1.73M
-59.77%28.14M
-80.90%181.22M
-55.63%341.13M
-74.80%142.69M
-71.38%69.94M
+398.80%948.92M
+403.80%768.75M
+541.82%566.36M
-25.32%244.35M
-121.87%-317.57M
-87.25%152.59M
-77.24%88.24M
+1004.86%327.20M
+87.30%1.45B
+134.79%1.20B
Add:Non-operating Income
-84.67%567.76K
-57.43%306.43K
+3.36%4.36M
+4.86%3.98M
+13.92%3.70M
+213.88%719.86K
+313.67%4.22M
+604.08%3.79M
+760.18%3.25M
+19.44%229.34K
-84.58%1.02M
-91.14%538.80K
-92.34%378.05K
-14.42%192.00K
+259.80%6.61M
+269.70%6.08M
+237.60%4.94M
+19.72%224.35K
-65.45%1.84M
+104.70%1.64M
Less:Non-operating Expense
+5.06%5.83M
-47.34%994.38K
-108.55%-3.04M
-7.60%9.67M
-40.01%5.55M
-62.31%1.89M
+269.22%35.51M
+144.16%10.46M
+211.20%9.26M
+84.13%5.01M
-64.76%9.62M
-72.16%4.29M
-65.37%2.97M
-49.84%2.72M
+83.91%27.29M
+17.62%15.40M
-30.08%8.59M
+14572.87%5.43M
+79.19%14.84M
+72.21%13.09M
Gross Profit
+33987.61%41.32M
+48.13%39.95M
-69.68%45.46M
-99.94%202.30K
-100.09%-121.92K
-58.61%26.97M
-84.05%149.94M
-56.28%334.46M
-75.75%136.69M
-73.05%65.16M
+378.00%940.32M
+433.95%765.00M
+566.45%563.76M
-24.90%241.82M
-123.50%-338.25M
-87.91%143.27M
-77.56%84.59M
+981.81%322.00M
+86.33%1.44B
+135.69%1.18B
Less:Income tax
+83.03%-6.40M
+38.49%6.35M
+51.93%-24.81M
-194.80%-48.98M
-31.61%-37.72M
-58.81%4.58M
-165.32%-51.62M
-124.45%-16.61M
-153.74%-28.66M
-69.39%11.13M
+138.44%79.02M
+213.49%67.95M
+248.50%53.33M
-24.90%36.36M
-216.87%-205.54M
-140.25%-59.87M
-188.93%-35.91M
+949.59%48.41M
+88.65%175.87M
+114.25%148.77M
Net Profit
+26.91%47.72M
+50.10%33.60M
-65.13%70.27M
-85.99%49.18M
-77.26%37.60M
-58.57%22.39M
-76.60%201.55M
-49.63%351.08M
-67.61%165.35M
-73.70%54.03M
+749.02%861.30M
+243.13%697.05M
+323.58%510.43M
-24.90%205.46M
-110.50%-132.71M
-80.40%203.15M
-64.19%120.50M
+987.71%273.59M
+86.01%1.26B
+139.13%1.04B
Net Profit from Continuing Operations
+26.91%47.72M
+50.10%33.60M
-65.13%70.27M
-85.99%49.18M
-77.26%37.60M
-58.57%22.39M
-76.60%201.55M
-49.63%351.08M
-67.61%165.35M
-73.70%54.03M
+749.02%861.30M
+243.13%697.05M
+323.58%510.43M
-24.90%205.46M
-110.50%-132.71M
-80.40%203.15M
-64.19%120.50M
+987.71%273.59M
+86.01%1.26B
+139.13%1.04B
Less:Minority Profit
-4013.61%-2.67M
+632.99%261.05K
+42.67%-56.52K
+224.45%24.68K
+335.09%68.17K
-32.48%-48.98K
---98.57K
---19.83K
--15.67K
---36.97K
----
--0.00
--0.00
--0.00
----
----
----
----
----
----
Net Profit of Parent Company Owners
+34.25%50.39M
+48.61%33.34M
-65.12%70.33M
-86.00%49.16M
-77.30%37.53M
-58.51%22.43M
-76.59%201.65M
-49.63%351.10M
-67.61%165.34M
-73.69%54.07M
+749.02%861.30M
+243.13%697.05M
+323.58%510.43M
-24.90%205.46M
-110.50%-132.71M
-80.40%203.15M
-64.19%120.50M
+987.71%273.59M
+86.01%1.26B
+139.13%1.04B
Basic EPS
+66.67%0.05
+50.00%0.03
-66.67%0.06
-87.10%0.04
-80.00%0.03
-60.00%0.02
-76.62%0.18
-50.00%0.31
-67.39%0.15
-72.22%0.05
+741.67%0.77
+155.35%0.62
+165.13%0.46
-55.00%0.18
-106.49%-0.12
-84.00%0.24
-64.86%0.17
+984.01%0.40
+79.61%1.85
+129.40%1.52
Diluted EPS
+66.67%0.05
+50.00%0.03
-66.67%0.06
-87.10%0.04
-80.00%0.03
-60.00%0.02
-76.62%0.18
-50.00%0.31
-67.39%0.15
-72.22%0.05
+741.67%0.77
+155.35%0.62
+165.13%0.46
-55.00%0.18
-106.59%-0.12
-83.67%0.24
-64.34%0.17
+998.90%0.40
+80.20%1.82
+129.62%1.49
Other Composite Income
+45.10%-52.69K
+36.81%-35.94K
-27.35%-115.81K
+32.21%-93.37K
-76.37%-95.97K
---56.88K
---90.94K
---137.74K
---54.41K
----
----
--0.00
--0.00
----
----
----
----
----
----
----
Other Composite Income of Parent Company Owners
+45.10%-52.69K
+36.81%-35.94K
-27.35%-115.81K
+32.21%-93.37K
-76.37%-95.97K
---56.88K
---90.94K
---137.74K
---54.41K
----
----
--0.00
--0.00
----
----
----
----
----
----
----
Total Composite Income
+27.09%47.67M
+50.32%33.56M
-65.18%70.16M
-86.01%49.09M
-77.31%37.50M
-58.67%22.33M
-76.61%201.46M
-49.65%350.94M
-67.62%165.30M
-73.70%54.03M
+749.02%861.30M
+243.13%697.05M
+323.58%510.43M
-24.90%205.46M
-110.50%-132.71M
-80.40%203.15M
-64.19%120.50M
+987.71%273.59M
+86.01%1.26B
+139.13%1.04B
Total Composite Income of Parent Company Owners
+34.45%50.33M
+48.83%33.30M
-65.16%70.21M
-86.02%49.06M
-77.35%37.44M
-58.61%22.38M
-76.60%201.56M
-49.65%350.96M
-67.62%165.28M
-73.69%54.07M
+749.02%861.30M
+243.13%697.05M
+323.58%510.43M
-24.90%205.46M
-110.50%-132.71M
-80.40%203.15M
-64.19%120.50M
+987.71%273.59M
+86.01%1.26B
+139.13%1.04B
Total Composite Income of Minority Owners
-4013.61%-2.67M
+632.99%261.05K
+42.67%-56.52K
+224.45%24.68K
+335.09%68.17K
-32.48%-48.98K
---98.57K
---19.83K
--15.67K
---36.97K
----
--0.00
--0.00
----
----
----
----
----
----
----
Deadline
Jun 30, 2026
Mar 31, 2026
Dec 31, 2025
Sep 30, 2025
Jun 30, 2025
Mar 31, 2025
Dec 31, 2024
Sep 30, 2024
Jun 30, 2024
Mar 31, 2024
Dec 31, 2023
Sep 30, 2023
Jun 30, 2023
Mar 31, 2023
Dec 31, 2022
Sep 30, 2022
Jun 30, 2022
Mar 31, 2022
Dec 31, 2021
Sep 30, 2021
Accounting Standard
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
2026/H12026/Q12025/FY2025/Q92025/H12025/Q12024/FY2024/Q92024/H12024/Q12023/FY2023/Q92023/H12023/Q12022/FY2022/Q92022/H12022/Q12021/FY2021/Q9

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.